Medicinal products, DK code - 33600000-6 - Pharmaceutical products (Budesonide, nebulizer suspension, 0.25 mg/ml, 2 ml per vial; Hydrocortisone, powder for solution, 100 mg per vial; Sodium chloride, solution for injection, 9 mg/ml, 5 ml per vial; Cephalexin powder for oral suspension 250 mg/5 ml, 40 g powder in a vial; Human insulin (Short-acting), solution for injection, 100 IU/ml, vial, 10 ml per vial; Ins

The supplied goods must not originate from the Russian Federation/Republic of Belarus/Islamic Republic of Iran. The Seller, by its own efforts, means, and at its own expense, in accordance with the terms of the Agreement, undertakes to deliver the Goods within the term of the Agreement (until 31.12.2026), but in no case later than 2 working days from the moment of receiving a request from the Buyer for the delivery of the Goods or a corresponding batch of Goods (in case of delivery of Goods in batches). Delivery of Goods is carried out to the address: Poltava region, Poltava city, Oleksandra Bidnoho street, 2.

Items: Budesonide, nebulizer suspension, 0.25 mg/ml, 2 ml per vial (Medicinal products for respiratory diseases) [CPV: 33670000-7]; Hydrocortisone, powder for solution, 100 mg per vial (Medicinal products for genitourinary diseases and hormones) [CPV: 33640000-8]; Sodium chloride, solution for injection, 9 mg/ml, 5 ml per vial (Miscellaneous medicinal products) [CPV: 33690000-3]; Cephalexin powder for oral suspension 250 mg/5 ml, 40 g powder in a vial (General anti-infective agents for systemic use, vaccines, antineoplastics and immunomodulators) [CPV: 33650000-1]; Human insulin (Short-acting), solution for injection, 100 IU/ml, vial, 10 ml per vial (Medicinal products for gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Insulin aspart (Rapid-acting), solution for injection, 100 IU/ml, 3 ml per vial (Medicinal products for gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Insulin glargine, solution for injection, 300 IU/ml, 1.5 ml per vial (Medicinal products for gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Insulin glargine, solution for injection, 100 IU/ml, 3 ml per vial (Medicinal products for gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Insulin degludec, solution for injection, 100 IU/ml, 3 ml per vial (Medicinal products for gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Enoxaparin sodium, solution for injection, 10000 anti-Xa IU/ml, 1.0 ml per vial (Medicinal products for blood diseases, hematopoietic organs and cardiovascular diseases) [CPV: 33620000-2]; Meropenem, powder for injection/infusion, 1 g per vial (General anti-infective agents for systemic use, vaccines, antineoplastics and immunomodulators) [CPV: 33650000-1]; Linezolid solution for infusion, 2 mg/ml, 300 ml per vial (General anti-infective agents for systemic use, vaccines, antineoplastics and immunomodulators) [CPV: 33650000-1]; Insulin glulisine, solution for injection, 100 IU/ml, 3 ml per vial (Medicinal products for gastrointestinal diseases and metabolic disorders) [CPV: 33610000-9]; Glucagen, lyophilized powder for solution for injection, 1 mg, vial (Medicinal products for genitourinary diseases and hormones) [CPV: 33640000-8]; Ringer's solution for infusion, 250 ml (Miscellaneous medicinal products) [CPV: 33690000-3]

Procuring entity: Communal enterprise "CHILDREN'S CITY CLINICAL HOSPITAL OF THE POLTAVA CITY COUNCIL"